Hovione

ExtremoChem specializes in the development and commercialization of innovative small synthetic molecules aimed at stabilizing biological substances under various stress conditions. The company provides a comprehensive array of services, including accelerated stability studies, pH stability assessments, thermal stability assessments, and aggregation analysis. By focusing on these critical areas, ExtremoChem supports life science research organizations, as well as the pharmaceutical, biotech, agrochemical, and chemical industries, in stabilizing medicines and proteins that are typically unstable at room temperature. This capability allows for improved storage and handling of sensitive biological products, enhancing their viability and effectiveness.

Delox, founded in 2018 and based in Cascais, Portugal, specializes in the design and development of bio-decontamination devices aimed at creating clean and safe environments. As a spin-off from the Faculty of Sciences of the University of Lisbon, the company has developed innovative technologies, including DeloxHP, a solid formulation that safely releases concentrated hydrogen peroxide vapor. This advancement allows for the creation of compact and cost-effective bio-decontamination solutions, such as the Delox Box. Delox's applications span various sectors, including the sterilization of medical devices, bio-decontamination of laboratory equipment, and room decontamination in hospitals, the food industry, and even space environments. The company focuses on providing non-toxic solutions to combat microorganisms, ensuring safe handling and transportation of hydrogen peroxide through its cartridge system.

SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.

AdaptTech is a biomedical company based in Birmingham, United Kingdom, that specializes in developing innovative wearable technologies aimed at enhancing the quality of life for individuals with physical disabilities. Founded in 2015, the company offers a range of products designed to assist clinicians in achieving better socket fitting and monitoring for patients who have lost a lower limb. Key offerings include the INSIGHT Scanner, which quickly creates a three-dimensional model of prosthetic sockets, the INSIGHT Wearable that collects real-time biometric data, and the INSIGHT App that provides users with easy access to their results. Through these advancements, AdaptTech seeks to improve the overall experience and outcomes for those relying on lower limb prosthetics.

Vaxdyn specializes in the development of vaccines and immunotherapies aimed at preventing infectious diseases, particularly those caused by antibiotic-resistant pathogens. The company employs innovative technologies, including antigens, immunomodulators, nanoparticles, and monoclonal antibodies, to create effective vaccines that help mitigate the impact of these drug-resistant infections on public health. Vaxdyn addresses customer inquiries through various channels, including phone, email, and online applications, ensuring accessible communication regarding their offerings.

CellmAbs is a biotechnology company based in Lisbon, Portugal, that specializes in developing therapies focused on glycoimmunology and oncology. Established in 2019 as a spin-off from NOVA University of Lisbon, CellmAbs has received funding from prominent Life Science Venture Capital firms in Portugal. The company is dedicated to creating innovative solutions for cancer treatment, particularly through immunotherapies and glycobiology, and has developed several preclinical candidates aimed at targeting solid tumors. With a team of experienced professionals, CellmAbs is positioned for rapid growth in the biotech sector, leveraging its expertise in cancer-specific glycan targets.

CellmAbs is a biotechnology company based in Lisbon, Portugal, that specializes in developing therapies focused on glycoimmunology and oncology. Established in 2019 as a spin-off from NOVA University of Lisbon, CellmAbs has received funding from prominent Life Science Venture Capital firms in Portugal. The company is dedicated to creating innovative solutions for cancer treatment, particularly through immunotherapies and glycobiology, and has developed several preclinical candidates aimed at targeting solid tumors. With a team of experienced professionals, CellmAbs is positioned for rapid growth in the biotech sector, leveraging its expertise in cancer-specific glycan targets.

SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.

Delox, founded in 2018 and based in Cascais, Portugal, specializes in the design and development of bio-decontamination devices aimed at creating clean and safe environments. As a spin-off from the Faculty of Sciences of the University of Lisbon, the company has developed innovative technologies, including DeloxHP, a solid formulation that safely releases concentrated hydrogen peroxide vapor. This advancement allows for the creation of compact and cost-effective bio-decontamination solutions, such as the Delox Box. Delox's applications span various sectors, including the sterilization of medical devices, bio-decontamination of laboratory equipment, and room decontamination in hospitals, the food industry, and even space environments. The company focuses on providing non-toxic solutions to combat microorganisms, ensuring safe handling and transportation of hydrogen peroxide through its cartridge system.

AdaptTech is a biomedical company based in Birmingham, United Kingdom, that specializes in developing innovative wearable technologies aimed at enhancing the quality of life for individuals with physical disabilities. Founded in 2015, the company offers a range of products designed to assist clinicians in achieving better socket fitting and monitoring for patients who have lost a lower limb. Key offerings include the INSIGHT Scanner, which quickly creates a three-dimensional model of prosthetic sockets, the INSIGHT Wearable that collects real-time biometric data, and the INSIGHT App that provides users with easy access to their results. Through these advancements, AdaptTech seeks to improve the overall experience and outcomes for those relying on lower limb prosthetics.

Anybrain is an artificial intelligence and data processing firm that specializes in developing an anti-fraud platform aimed at securing online gaming and esports. The company's innovative platform utilizes machine learning algorithms for real-time continuous player identification by analyzing user interaction patterns through keyboard and mouse inputs, without the need for external sensors. This technology enables the entertainment industry to proactively detect game fraud and abnormal behaviors, ensuring a fair and secure gaming experience.

Performetric is a real-time monitoring system that allows the management of mental fatigue in a non-invasive way that aims to develop leisure and work context-aware environments that may improve the quality of life, wellness, mental health and individual performance. Moreover, it also aims to support a better management of the employees and their work time. This translates into a positive impact in the organization’s productivity and an increased quality of life and better health of the employees.